Coagulant Therapeutics Corporation
PrivateTotal Funding Raised
$36M
Company Overview
Coagulant Therapeutics Corporation is a biotechnology company that develops novel therapeutics targeted to the coagulation cascade for the treatment of acute bleeding and related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coagulant Therapeutics Corporation Comparables
Compare Coagulant Therapeutics Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cayuga Biotech | 78% | |
| VarmX | 75% | |
| Novo Nordisk | 66% | |
Coagulant Therapeutics Corporation Funding Rounds
Historical fundraising activity
Coagulant Therapeutics Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Financial Group | Series A |
| Digital Transformation Capital Partners | Series A |
| Korea Omega Investment Corp | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 72% MoM.
- Jun 4, 2025
Grew 133% QoQ from 3 to 7 employees.
Coagulant Therapeutics Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Coagulant Therapeutics Corporation's valuation, stock price, and market status.